News | June 23, 2015

Extensive survey finds most users value ease of use and functionality, prefer bundling systems

ECRI Institute, linear accelerators, linac, purchase, survey

June 23, 2015 - The ECRI Institute released a new techIQ brief on key factors to consider when purchasing a linear accelerator (linac) for external beam radiation therapy. The report is a compilation of results from a survey of hundreds of users of linac-based radiosurgery systems; participants were asked to rate the functions and features of the four major linac vendors: Accuray, Brainlab, Elekta and Varian Medical Systems.

Among the factors considered were:

  • Ease of use;
  • Functionality;
  • Reliability;
  • Siting requirements;
  • Implementation;
  • Service;
  • Vendor support;
  • Training; and
  • Cost

 

According to the survey results, the linac models with the highest overall ratings scored the highest for ease of use, functionality, imaging capabilities and device interoperability.

ECRI also sought to determine the different ways that linacs are employed. The survey found that nearly half of all respondents typically utilize their linac for both standard radiotherapy and stereotactic radiosurgery.

Fifty-nine percent of those surveyed use a treatment planning system and linac from the same manufacturer, and 47 percent use an oncology information system that is also sold by the linac manufacturer. This bundling of systems and services has been a growing trend in the marketplace over the past few years, offering benefits such as higher equipment discounts, reduced training expenses and coinciding service contracts.

The ECRI Institute is an independent nonprofit organization that conducts research into the most effective approaches for improving patient care.  

For more information: www.ecri.org


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now